Company: BIAF
Filing Date: 2025-09-30
Form Type: 8-K
Source: 0001493152-25-016366
Chunk: 3

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-30
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item
9.01 Financial Statements and Exhibits.

(d)
Exhibits

  Exhibit No.      Description                                                                                                                            
          1.1      Placement Agency Agreement, dated as of September 25, 2025, by and between bioAffinity Technologies, Inc. and WallachBeth Capital LLC  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          4.1      Form of Pre-Funded Warrant                                                                                                             
         10.1      Form of Securities Purchase Agreement                                                                                                  
         99.1      Press Release dated September 29, 2025                                                                                                 
         99.2      Press Release dated September 30, 2025                                                                                                 
          104      Cover Page Interactive                                                                                                                 

  -4-  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K
to be signed on its behalf by the undersigned hereunto duly authorized.

  Date:      September 30, 2025      BIOAFFINITY TECHNOLOGIES, INC.                                             
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                                     By:                                 /s/                                    
                                     Name:                               Maria Zannes                           
                                     Title:                              President and Chief Executive Officer  

  -5-